The use of sirolimus (rapamycin) in the management of refractory inflammatory bowel disease in children

Our data provide evidence that sirolimus seems to be effective as rescue therapy in a subgroup of children with severe IBD refractory to conventional therapies by inducing both clinical remission and mucosal healing.